Bacterin International Holdings Inc (NYSEMKT:BONE), the small capped drug maker saw its market valuation balloon upwards during trading on 20thMarch, on the back of its 4Q results announcements on 19th March, after markets closed and the publication of its research data on its treatment procedure OsteoSponge® in Orthopedics Today. The treatment is for alleviating the suffering of patients suffering from “Foot and Ankle Arthrodeses”. Bacterin International Holdings Inc (NYSEMKT:BONE) stock opened today at $1.02 and is currently trading at $1.03. The stock showed a positive weekly performance of 35.21%.
The Mast Therapeutics Inc (NYSEMKT:MSTX) On Feb. 27 announced that it has completed its acquisition of Aires Pharmaceuticals, Inc. Aires’ lead product candidate, AIR001, is an intermittently nebulized formulation of nitrite that has orphan drug designation in the U.S. and European Union for the treatment of pulmonary arterial hypertension. Under the terms of the all-stock transaction, which was completed on February 27, 2014, Aires became a wholly-owned subsidiary of Mast Therapeutics in exchange for a total of 5.2 million shares of Mast common stock, representing approximately 5% of Mast’s outstanding common stock. Mast Therapeutics Inc (NYSEMKT:MSTX) stock opened at $0.85, in current trading session and currently is at $0.770, by loosing -7.00%.The 52 week range of $0.40-$1.10. Company’s market capitalization is $78.98 million.
Aastrom Biosciences Inc (NASDAQ:ASTM) announced that its executives led by CEO and President Nick Colangelo will present at the Regen Med Investor Day 2014. The one-day event will be held at Metropolitan Club in New York City on March 26. The event is important for investors as it will involve commercial and clinical experts addressing the outlook of the regenerative medicine solutions. Aastrom is a provider of regenerative medicine products and the March 26 event will exclusively focus on regenerative therapies. The event is organized by Alliance for Regenerative Medicine and financial services providers Piper Jaffray and Maxim Group. Shares of Aastrom Biosciences Inc (NASDAQ:ASTM) soared 25.19 percent to $4.97 in the previous session. Aastrom Biosciences Inc (NASDAQ:ASTM) stock is currently trading at $5.97 .The EPS of the stock is -9.48. Company’s market capitalization is $26.15 million.
BG Medicine, Inc. (NASDAQ:BGMD) a leading developer of unmet medical needs, has announced its fourth quarter and full year results for the period ending December 31, 2013. Going forward the company plans to develop market demand for its new addition Galectin-3-testing as well as, explore new indications and clinical claims for BGM galectin-3 Test.BG Medicine, Inc. (NASDAQ:BGMD) stock opened the session at $1.90, and now is at $1.76. The 52 week range of the BGMD stock remained $0.55-$2.36 and the day range was $1.73-$2.00.